期刊文献+

NT-proBNP评估无心衰症状尿毒症患者容量负荷的临床研究 被引量:5

A clinical study of NT-proBNP assessment of capacity load in patients with no heart failure in uremia
下载PDF
导出
摘要 目的:观察无心衰症状尿毒症患者透析前血浆N末端B型脑钠肽前体(NT-proBNP)水平在容量负荷评估中的临床价值。方法:回顾性分析无心衰症状尿毒症患者62例透析前收缩压、血肌酐、全身水肿程度及脱水量,并进行血浆NT-proBNP水平与上述各项指标的相关性研究。结果:透析前血浆NT-proBNP水平(5 111.9±2 783.6)pg/m L,与收缩压、血肌酐水平、脱水量及全身水肿程度呈明显正相关(P<0.05)。结论:血NT-proBNP水平可能是判断早期容量负荷过高的一个敏感指标,对临床容量负荷评估有重要的意义。 Objective:To observe the clinical value of the level of N terminal B type natriuretic peptide(NT-pro BNP)in the volume load assessment of patients with uremia without heart failure before dialysis.Methods:We made a retrospective analysis of 62 cases of uremic patients with non heart failure symptoms,including pre dialysis systolic blood pressure,serum creatinine, systemic edema and dehydration,and the correlation between plasma NT-pro BNP level and the above indicators were performed. Results:The level of plasma NT-pro BNP was(5 111.9 ± 2 783.6)pg/mL before dialysis was positively correlated with the systolic pressure,serum creatinine level,dewater and the degree of systemic edema(P 〈 0.05).Conclusion:The level of serum NT-pro BNP mW be a sensitive index to judge the early volume overload,which is of great significance for the assessment of clinical volume load.
作者 徐敏 李中 杨中香 刘国梅 Xu Min;Li Zhong;Yang Zhongxiang;Liu Guomei(Depaztment of Nephrology, the Second People's Hospital of Jingzhou City(Hubei Province)43400)
出处 《中国社区医师》 2018年第15期126-127,共2页 Chinese Community Doctors
关键词 NT—proBNP 尿毒症 透析 容量负荷心衰 NT-pro BNP Uremia dialysis Capacity load Heart failure
  • 相关文献

参考文献1

二级参考文献13

  • 1Sun L,Sun Y,Zhao X,et al.Predictive role of BNP and NT pro BNP in hemodialysis patients[J].Nephron Clin Pract,2008,100:c178-c184.
  • 2Zhou YL,L J,Sun F,et al.Calf bioimpedance ratio im-proves dry weight assessment and blood pressure con-trol in hemodialysis patients[J].Am J Nephrol,2010,32:109-116.
  • 3McCullough PA,Duc P,Omland T,et al.B-type natri-uretic peptide and renal function in the diagnosis of heart failure:an analysis from the Breathing Not Prop-erly Multinational Study[J].Am J Kidney Dis,2003,41:571-579.
  • 4Omland T,Hagve TA.Natriuretic peptides:Physiologic and analytic considerations[J].Heart Fail Clin,2009,5:471-487.
  • 5Mallamaci F,Zoccali C,Tripepi G,et al.CREED Inves-tigators.The Cardiovascular Risk Extended Evalua-tion.Diagnostic potential of cardiac natriuretic pep-tides in dialysis patients[J].Kidney Int,2001,59:1559-1566.
  • 6Chazot C,Vo-Van C,Zaoui E et al.Fluid overload cor-rection and cardiac history influence brain natriuret-ic peptide evolution in incident hemodialysis patients [J].Nephrol Dial Transplant,2011,26:2630-2634.
  • 7Liu H,Zhang YZ,Gao M,et al.Elevation of B-type na-triuretic peptide is a sensitive marker of left ven-tricular diastolic dysfunction in patients with main tenance haemodialysis[J].Biomarkers,2010,15:533-537.
  • 8Fagugli RM,Palumbo B,Ricciardi D,et al.Associa tion between brain natriuretic peptide and extracellu-Jar water in hemodialysis patients[J].Nephron Clin Pract,2003,95:c60-c66.
  • 9Horl WH.Natriuretic peptide in acute and chronic kid-ney disease and during renal replacement therapy[J].J Investing Med,2005,53:366-370.
  • 10Roueff S,Zamperetti M,Bortin D,Guidi G,De Fanti E,Schiavon R.Significance of plasma B-type natri-uretic peptide in hemodialysis patients:Blood sample timing and comorbidity burden[J].ASAIO J,2007,53:587-591.

共引文献4

同被引文献40

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部